Middle East & Africa Sepsis Diagnostics Market Size & Outlook
Middle East & Africa sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
MEA sepsis diagnostics market highlights
- The MEA sepsis diagnostics market generated a revenue of USD 30.4 million in 2022.
- The market is expected to grow at a CAGR of 7.6% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2023 to 2030.
MEA data book summary
| Market revenue in 2022 | USD 30.4 million |
| Market revenue in 2030 | USD 54.6 million |
| Growth rate | 7.6% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.0% of the global sepsis diagnostics market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 431.0 million by 2030.
Blood culture media was the largest segment with a revenue share of 39.14% in 2022. Horizon Databook has segmented the Middle East & Africa sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The growing number of sepsis cases, driven by factors such as high rates of infectious diseases, poor sanitation, and limited access to clean water, has heightened the need for effective sepsis diagnostics. Many countries in the MEA region are investing in improvements in healthcare infrastructure, including establishing modern hospitals and diagnostic centers with state-of-the-art technology.
Government initiatives aimed at strengthening healthcare systems, such as the implementation of national health plans and policies focusing on infectious disease control, are bolstering the market for sepsis diagnostics.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA sepsis diagnostics market size, by country, 2018-2030 (US$M)
Middle East & Africa Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
